Home Amgen wins approval for second biotech cholesterol drug
 

Keywords :   


Amgen wins approval for second biotech cholesterol drug

2015-08-31 08:29:18| Biotech - Topix.net

This undated image provided by Amgen Inc. shows Repatha. Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.

Tags: drug approval wins biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.05US bans China crypto-miner from nuclear base area
14.05Cow dung's key role in India's energy industry
14.05May hay stocks provide early perspective on 2024 hay supply
13.05Dantex announces new digital director for Pico division
13.05Tonny De Beer Joins First Quality
13.05Join us for the 2024 Global Hog Industry Virtual Conference
13.05New version of Chat-GPT can teach maths and flirt
13.05Eastern North Pacific Tropical Weather Outlook
More »